期刊
NUCLEIC ACIDS RESEARCH
卷 41, 期 2, 页码 -出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gks1037
关键词
-
资金
- J Klaus Tschira Stiftung gGmbH
- European Union's Seventh Framework Programme for Research (EU FP7) SyBoSS [242129]
- Deutsche Forschungsgemeinschaft (German Research Foundation) [SPP1356 BU1400/3-1, SFB655]
- Medical Systems Biology, University Hospital and Medical Faculty, Carl Gustav Carus, University of Technology, Dresden, Germany
Targeted genome engineering has become an important research area for diverse disciplines, with site-specific recombinases (SSRs) being among the most popular genome engineering tools. Their ability to trigger excision, integration, inversion and translocation has made SSRs an invaluable tool to manipulate DNA in vitro and in vivo. However, sophisticated strategies that combine different SSR systems are ever increasing. Hence, the demand for additional precise and efficient recombinases is dictated by the increasing complexity of the genetic studies. Here, we describe a novel site-specific recombination system designated Vika/vox. Vika originates from a degenerate bacteriophage of Vibrio coralliilyticus and shares low sequence similarity to other tyrosine recombinases, but functionally carries out a similar type of reaction. We demonstrate that Vika is highly specific in catalyzing vox recombination without recombining target sites from other SSR systems. We also compare the recombination activity of Vika/vox with other SSR systems, providing a guideline for deciding on the most suitable enzyme for a particular application and demonstrate that Vika expression does not cause cytotoxicity in mammalian cells. Our results show that Vika/vox is a novel powerful and safe instrument in the 'genetic toolbox' that can be used alone or in combination with other SSRs in heterologous hosts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据